Paper39596374
Identification of Functional Immune Biomarkers in Breast Cancer Patients.
Derakhshandeh R and 12 others. Int J Mol Sci, 2024. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Identification of Functional Immune Biomarkers in Breast Cancer Patients. Papers, record 39596374. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596374
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Natural Killer T-Cells | Major topic |
| Biomarkers, Tumor | Major topic |
| Interferon-gamma | Major topic |
| Tumor Microenvironment | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Lymphocytes, Tumor-Infiltrating | |
| B7-H1 Antigen | |
| Adult | |
| Aged |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 CA162273 | NCI NIH HHS | United States | R21CA162273 | PubMed | NIH RePORTER |
| R21 CA199544 | NCI NIH HHS | United States | R21CA199544 | PubMed | NIH RePORTER |
| NIH/NCI R21 CA162273, R21 CA16227, R21 CA199544, the American Cancer Society IRG-18-160-16-IRG, and TEDCO | NIH, TEDCO, ACS | PubMed | PubMed |
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11985789 | Expansion of lung V alpha 14 NKT cells by administration of alpha-galactosylceramide-pulsed dendritic cells. | Jpn J Cancer Res | 2002 | https://conductscience.org/library/papers/11985789 | PubMed |
| 2 | 27076627 | VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/27076627 | PubMed |
| 3 | 25512551 | Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25512551 | PubMed |
| 4 | 24812403 | Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. | Science | 2014 | https://conductscience.org/library/papers/24812403 | PubMed |
| 5 | 11564825 | Loss of IFN-gamma production by invariant NK T cells in advanced cancer. | J Immunol | 2001 | https://conductscience.org/library/papers/11564825 | PubMed |
| 6 | 7506235 | Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand. | Immunogenetics | 1994 | https://conductscience.org/library/papers/7506235 | PubMed |
| 7 | 1678734 | Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. | Int J Cancer | 1991 | https://conductscience.org/library/papers/1678734 | PubMed |
| 8 | 23648271 | Targeted cancer immunotherapy. | Curr Opin Pharmacol | 2013 | https://conductscience.org/library/papers/23648271 | PubMed |
| 9 | 1692078 | LAG-3, a novel lymphocyte activation gene closely related to CD4. | J Exp Med | 1990 | https://conductscience.org/library/papers/1692078 | PubMed |
| 10 | 10700230 | Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. | Nat Med | 2000 | https://conductscience.org/library/papers/10700230 | PubMed |
| 11 | 26779443 | Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents. | Front Oncol | 2015 | https://conductscience.org/library/papers/26779443 | PubMed |
| 12 | 10319859 | Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. | Nat Genet | 1999 | https://conductscience.org/library/papers/10319859 | PubMed |
| 13 | 11035065 | Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation. | J Immunol | 2000 | https://conductscience.org/library/papers/11035065 | PubMed |
| 14 | 15556688 | The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients. | Hum Immunol | 2004 | https://conductscience.org/library/papers/15556688 | PubMed |
| 15 | 7500037 | TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1. | J Exp Med | 1995 | https://conductscience.org/library/papers/7500037 | PubMed |
| 16 | 20868731 | Loss of BRCA1 leads to an increased sensitivity to Bisphenol A. | Toxicol Lett | 2010 | https://conductscience.org/library/papers/20868731 | PubMed |
| 17 | 18215290 | Comparison of mouse mammary gland imaging techniques and applications: reflectance confocal microscopy, GFP imaging, and ultrasound. | BMC Cancer | 2008 | https://conductscience.org/library/papers/18215290 | PubMed |
| 18 | 19446558 | Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells. | J Immunol Methods | 2009 | https://conductscience.org/library/papers/19446558 | PubMed |
| 19 | 12847141 | Cross-presentation of disialoganglioside GD3 to natural killer T cells. | J Exp Med | 2003 | https://conductscience.org/library/papers/12847141 | PubMed |
| 20 | 15756017 | A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/15756017 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930146 | The Correlation Between iNKT Cells and Malignant Tumors: A Meta-Analysis. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42930146 | PubMed |
| 42194097 | Natural Killer T Cell Function in Lymphoma Patients. | Biomolecules | 2026 | https://conductscience.org/library/papers/42194097 | PubMed |
| 41511636 | Zerumbone mediated CD1d inhibition suppresses epithelial to mesenchymal transition in triple negative breast cancer. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41511636 | PubMed |
| 41430741 | TELO2 mediates parabens-induced breast carcinogenesis: a comprehensive network analysis. | BMC Pharmacol Toxicol | 2025 | https://conductscience.org/library/papers/41430741 | PubMed |
| 41089104 | Association of Chronic Inflammation-Associated Cancer With Cytokines. | Cureus | 2025 | https://conductscience.org/library/papers/41089104 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| LAG3 | 3902 | PubTator's text mining | https://conductscience.org/library/genes/3902 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39596374
GET https://conductscience.org/api/papers/v1/39596374/references?page=2